Clinical Trials Logo

Filter by:
NCT ID: NCT05222360 Completed - Nutrition, Healthy Clinical Trials

Improvement of Body Image Flexibility in High School Female Athletes Doing Educational About Nutrition and Body Image

Start date: August 1, 2020
Phase:
Study type: Observational

Evaluation of increase in body flexibility in female high school athletes undergoing education on nutrition and body image

NCT ID: NCT05222022 Completed - Healthy Clinical Trials

Engineering Evaluation of an Eye Movement Monitor Device

Start date: February 18, 2022
Phase: N/A
Study type: Interventional

The objective of the engineering evaluation is to verify and validate the design of an eye movement monitor device, the Retitrack, for recording, viewing, measuring, and analyzing temporal characteristics of fixation and saccadic responses in human eyes when viewing a visual stimulus. This engineering evaluation is not an applicable clinical trial. This is a design validation of the mechanism of action of the device to measure eye movement. This is not a clinical trial to evaluate the effect of an intervention on biomedical or other health-related outcomes.

NCT ID: NCT05221905 Completed - Arterial Stiffness Clinical Trials

Effects of Inorganic Nitrate and Intensity of Exercise on Cardiovascular Health in Post-Menopausal Females

Start date: November 1, 2021
Phase: Phase 1
Study type: Interventional

Post-menopausal females experience elevated cardiovascular disease risk (CVD), compared to premenopausal females and age-matched males. Current exercise guidelines appear inadequate to ameliorate this increased risk and higher intensity exercise may be necessary. Oral inorganic nitrate supplementation enhances both exercise performance and CVD risk profile in several clinical conditions. However, the effects of this intervention in post-menopausal females is unexplored.

NCT ID: NCT05221866 Completed - Opioid Use Clinical Trials

Efficiency And Quality In Post-Surgical Pain Therapy After Discharge

EQUIPPED
Start date: March 14, 2022
Phase: N/A
Study type: Interventional

Following inpatient surgery, more than 80% of patients are prescribed opioids for use after discharge, yet up to 90% of patients report leftover opioids, and only 16% maximize non-opioid therapy. The proposed research seeks to test a provider-facing decision support tool and a patient-facing smartphone app to reduce the amounts of opioids prescribed and taken following discharge, while ensuring effective treatment of pain after surgery.

NCT ID: NCT05221723 Completed - Clinical trials for Spinal Cord Injuries

Functional Interval Training for People With Spinal Cord Injury and Their Care Partners

SCI-FIT
Start date: February 18, 2022
Phase: N/A
Study type: Interventional

Functional Interval Training for People with Spinal Cord Injury and Their Care Partners (SCI-FIT) aims to address barriers to physical activity for people with spinal cord injury and their care partners. This research study provides free, twice weekly group-based, adaptable exercise classes for people with spinal cord injury and their care partners.

NCT ID: NCT05221125 Completed - Clinical trials for Musculoskeletal Pain

Multimodal Management of Neck and Back Pain in the Emergency Department (Multi-ED)

Start date: June 6, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the feasibility and acceptability of psychologically-informed physical therapy (PIPT) in the ED in a pilot study of ED patients with neck or back pain. We will conduct a single-site, prospective trial comparing the combined program in one group with a usual care-only group. Primary outcomes will focus on feasibility based on recruitment and retention rates, and acceptability based on a 5-point patient satisfaction scale, while secondary outcomes will include pain severity, pain interference, anxiety, physical function, opioid use, repeat ED visits, and hospitalizations at 1 hour and at 24 hours, 1 month and 3 months after ED discharge. We will use pilot study results to develop a protocol for a larger pragmatic randomized clinical trial designed to rigorously evaluate PIPT in the ED combined with Spine Health follow up for ED patients with neck or back pain. We will perform a process evaluation of our proposed clinical trial study design, including characterizing and quantifying the degree of CBT and PT components used by treating PTs while in the ED and during Spine Health follow up, number of Spine Health visits attended in the first month, and integration into usual ED care. Qualitative interviews will be used to identify facilitators, barriers and potential solutions to intervention and research study procedures based on the patients' experience.

NCT ID: NCT05220943 Completed - Anxiety Clinical Trials

The Effect of a Non-Operating Room Anesthesia (NORA) Safety Video on Clinician Anxiety and Perceived Self-Efficacy

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of a non-operating room anesthesia (NORA) safety video on clinician anxiety and perceived self-efficacy.

NCT ID: NCT05220254 Completed - Smoking Cessation Clinical Trials

Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients

NCT ID: NCT05219994 Completed - Type 2 Diabetes Clinical Trials

Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum

Start date: September 9, 2020
Phase: N/A
Study type: Interventional

Our overall goal is to advance our understanding of the contribution of the carotid body chemoreceptors in glucose regulation and the development of type 2 diabetes.

NCT ID: NCT05219838 Completed - Clinical trials for Healthy Participants

Binding and Effects of Lu AG06466 in the Brain of Healthy Men

Start date: January 18, 2022
Phase: Phase 1
Study type: Interventional

This study is being done to learn about the binding of Lu AG06466 and its major breakdown product (Lu AG06988) in the brain of healthy men having received multiple doses of Lu AG06466. As the binding will result in inhibition of an enzyme in the endocannabinoid system called monoacylglycerol lipase (MAGL), the effects on this system will be evaluated both in the blood and cerebrospinal fluid and compared to the binding in the brain.